ADC Approval Buoys Spirits in Cancer Treatment Space
The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for…
The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for…
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
Update (15/05/2020): The Swiss biotech ADC Therapeutics has priced its IPO on the New York…
The Swiss biotech ADC Therapeutics has withdrawn its application for a €182M ($200M) Nasdaq IPO,…
Two companies based in Lausanne, Switzerland -- ADC Therapeutics and the genomics company SOPHiA Genetics…
Update (09/07/2019): The Switzerland-based ADC Therapeutics has completed the final closing of a €271M ($303M)…
The Swiss city of Lausanne is perhaps best known as a hub of international sport,…
Besides struggling with ambitious New Year’s resolutions and post-holiday diets, January is a time where…
ADC Therapeutics has tested its antibody-drug conjugate technology in drug-resistant cancers, yielding encouraging results. Swiss biotech…
Tis the season for Glühwein, Tannenbäume, and lights in Berlin, and Labiotech is celebrating with…
ADCs are overcoming the challenges of first generations and returning with a vengeance. I attended the…
New year, new list: here are the 10 hottest Biotech companies I will watch closely…